Duncan Jarvies

Or maybe what they're actually interested in, you know, ivory tower, academics working away and actually people just want to know what's good to eat.

Yeah, easy.

Great.

Well, there you go.

So that's two things.

One thing to start doing, which is some exercise.

And one thing to stop doing, which is worrying about saying it's quiet.

So, as we record this, Carl, you have just come back from Sydney.

Well, was there any sunshine?

All those bushfires?

Have you seen photos of Sydney recently?

Somebody's got to do it, haven't they?

That's when I first arrived here and people were starting to talk about the problems with screening.

I never really understood it until, I can't remember who it was, sat me down and explained what lead time bias was.

It was just one of those light bulb moments where a different perspective kind of helps you see clear.

And Ray Moynihan, who works with the BMJ and was also at the conference, actually did a quick interview with Michael for us.

Yeah.

Well, when overdiagnosis does come around, we're going to be there with some talk evidence as well.

So make sure you keep subscribing so you can hear us.

And do you have a conflict of interest to declare there, Helen?